Title: Methods for Normalizing and for Identifying Small Nucleic Acids
Patent Number: 8,741,569
Filed: Oct. 23, 2009
Lead Inventor: Kai Lao, Applied Biosystems (Life Technologies)
Title: PHD2 Inhibition for Blood Vessel Normalization and Uses Thereof
Patent Number: 8,741,862
Filed: Jan. 20, 2010
Lead Inventor: Peter Carmeliet, Life Science Research Partners
Title: Compositions and Methods for Inhibiting Expression of Transthyretin
Patent Number: 8,741,866
Filed: March 1, 2012
Lead Inventor: Dinah Sah, Alnylam Pharmaceuticals
Title: RNA Sequence-specific Mediators of RNA Interference
Patent Number: 8,742,092
Filed: March 1, 2012
Lead Inventor: Thomas Tuschl, Max Planck Institute
Title: Methods of Novel Therapeutic Candidate Identification through Gene Expression Analysis in Vascular-related Diseases
Patent Number: 8,741,861
Filed: March 27, 2009
Inventor: David Mann, Vascular Biosciences
Title: Panel of microRNAs that Silence the MCL-1 Gene and Sensitize Cancer Cells to ABT-263
Patent Number: 8,742,083
Filed: Dec. 23, 2010
Lead Inventor: Dimitri Semizarov, AbbVie